Celerion
Belfast, United Kingdom
Research institute in Belfast, Northern Ireland
22-24 Lisburn Rd, Belfast BT9 6AD
About Celerion
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Philip Morris Products S.A.
3
Celtaxsys, Inc.
2
Proteostasis Therapeutics, Inc.
2
AbbVie
1
Alexion
1
Allergan
1
Boehringer Ingelheim
1
British American Tobacco (Investments) Limited
1
CSL Behring
1
Chiesi Farmaceutici S.p.A.
1
F2G Biotech GmbH
1
Clinical Trials at Celerion
During the past decade, Celerion conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis
2012-02-01
2012-12-01
Completed
10
Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients
2012-10-01
2013-10-01
Completed
55
Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations
2013-05-01
2013-06-01
Completed
84
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
2013-08-07
2017-08-15
Terminated
59
Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients
2013-09-01
2014-11-01
Completed
17
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects
2012-11-01
2013-05-01
Completed
65
Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam
2014-09-01
2014-10-01
Completed
20
A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2)
2014-09-01
2015-04-01
Completed
28
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Celerion" #1 sponsor was "Philip Morris Products S.A." with 3 trials, followed by "Celtaxsys, Inc." with 2 trials
sponsored, "Proteostasis Therapeutics, Inc." with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Alexion"
with 1 trials sponsored. Other sponsors include 18 different institutions and
companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Celerion"
#1 collaborator was "Celerion" with 5 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Celerion Ltd" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator and "Imperial Brands PLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Celerion
According to Clinical.Site data, the most researched conditions in "Celerion" are
"Cystic Fibrosis" (10 trials), "Healthy" (3 trials), "Smoking" (3 trials), "Asthma" (2 trials) and "Healthy Subjects" (2 trials). Many other conditions were trialed in "Celerion" in a lesser frequency.
Clinical Trials Intervention Types at Celerion
Most popular intervention types in "Celerion" are "Drug" (27 trials), "Other" (5 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "CIG" (2 trials), "CTX-4430" (2 trials), "PTI-428" (2 trials) and "ACT-389949 (Group C1 dose to be selected)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Celerion
The vast majority of trials in "Celerion" are
31 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Celerion
Currently, there are NaN active trials in "Celerion".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 26 completed trials in Celerion,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Celerion, 22 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".